Phase II trial of etoposide in the management of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D005047:Etoposide / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D014594:Uterine Neoplasms / Q000188:drug therapy*
D005047:Etoposide; D011034:Podophyllotoxin